| |
| Issue |
Title |
| |
| No 11 (2023) |
Atezolizumab and bevacizumab in the treatment of advanced hepatocellular cancer with adverse factors and tumor thrombosis |
Abstract
PDF (Rus)
|
|
I. A. Dzhanyan, M. N. Khagazheeva, V. V. Breder, D. I. Yudin, I. V. Pogrebnyakov, A. E. Kuzminov, E. Yu. Antonova, N. M. Starostin |
| |
| No 9 (2022) |
Adjuvant immunotherapy of operable non-small cell lung cancer: achievements and treatment prospects |
Abstract
PDF (Rus)
|
|
E. S. Denisova, K. K. Laktionov, M. A. Ardzinba, E. V. Reutova |
| |
| No 9 (2022) |
Key differences between anti-PD-1/PD-L1 inhibitors |
Abstract
PDF (Rus)
|
|
N. V. Zhukova, R. V. Orlova, E. A. Kaledina, P. A. Naymushina, A. M. Malkova, N. P. Beliak |
| |
| No 9 (2022) |
Immunotherapy of advanced hepatocellular carcinoma: case report and literature review |
Abstract
PDF (Rus)
|
|
K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, R. R. Abdeev, N. I. Sultanbaeva, V. G. Nigmatullin, E. V. Popova |
| |
| No 20 (2021) |
Results of combined nivolumab and ipilimumab therapy in patients with cancer |
Abstract
PDF (Rus)
|
|
M. A. Lyadova, V. K. Lyadov, O. A. Pardabekova, I. A. Pokataev, M. E. Ivannikov, Ya. V. Koroleva, E. S. Chernysheva, K. V. Lyadov |
| |
| No 9 (2021) |
inhibitor prolgolimab in metastatic skin melanoma: recent data and experience of use |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| No 9 (2021) |
Five-year results of nivolumab for the treatment of non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center |
Abstract
PDF (Rus)
|
|
D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, V. V. Breder, M. S. Ardzinba, E. V. Reutova, O. I. Borisova |
| |
| No 9 (2021) |
Immunotherapy in elderly patients |
Abstract
PDF (Rus)
|
|
M. A. Lyadova, V. K. Lyadov |
| |
| 1 - 8 of 8 Items |
|
